We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-3.04%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.1B
AUM Growth
+$282M
Cap. Flow
+$321M
Cap. Flow %
15.28%
Top 10 Hldgs %
31.03%
Holding
185
New
43
Increased
48
Reduced
68
Closed
26

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$37.3M
2
SON icon
Sonoco
SON
+$27.1M
3
MTCH icon
Match Group
MTCH
+$24.8M
4
PLD icon
Prologis
PLD
+$23.9M
5
SLB icon
SLB Ltd
SLB
+$19.3M

Top Sells

Rank Stock Value
1
MTB icon
M&T Bank
MTB
+$36.8M
2
ZM icon
Zoom
ZM
+$25.3M
3
WBD icon
Warner Bros
WBD
+$23.6M
4
LYFT icon
Lyft
LYFT
+$22.3M
5
EXPE icon
Expedia Group
EXPE
+$20.5M

Sector Composition

Rank Sector Weight
1 Technology 18.46%
2 Consumer Discretionary 13.65%
3 Healthcare 10.33%
4 Communication Services 7.49%
5 Consumer Staples 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAG icon
101
Conagra Brands
CAG
$7.07B
$6.27M 0.3%
225,792
-35,143
-13% -$998K
SNX icon
102
TD Synnex
SNX
$20.3B
$6.16M 0.29%
52,521
-131,637
-71% -$15.8M
EQX icon
103
Equinox Gold
EQX
$13.5B
$6.13M 0.29%
1,220,841
+269,975
+28% +$1.51M
TNC icon
104
Tennant Co
TNC
$1.18B
$6.05M 0.29%
+74,204
New +$6.53M
OXM icon
105
Oxford Industries
OXM
$556M
$5.98M 0.28%
75,915
+51,221
+207% +$4.02M
IIIN icon
106
Insteel Industries
IIIN
$626M
$5.81M 0.28%
+215,159
New +$6.26M
HCSG icon
107
Healthcare Services Group
HCSG
$1.5B
$5.62M 0.27%
483,511
+195,516
+68% +$2.23M
WABC icon
108
Westamerica Bancorp
WABC
$1.35B
$5.44M 0.26%
+103,648
New +$5.55M
ZION icon
109
PUT
Zions Bancorporation
ZION
$10.3B
$5.42M 0.26%
+100,000
New +$5.48M
INCY icon
110
Incyte
INCY
$24.6B
$5.3M 0.25%
76,771
-11,981
-13% -$854K
RGP icon
111
Resources Connection
RGP
$145M
$5.16M 0.25%
604,617
+48,880
+9% +$412K
FLGT icon
112
Fulgent Genetics
FLGT
$524M
$4.78M 0.23%
259,010
+9,263
+4% +$181K
PATH icon
113
UiPath
PATH
$8.08B
$4.58M 0.22%
360,149
+5,027
+1% +$66.4K
NTR icon
114
Nutrien
NTR
$31.6B
$4.28M 0.2%
95,590
-14,823
-13% -$704K
MYE icon
115
Myers Industries
MYE
$1.25B
$4.27M 0.2%
+386,653
New +$4.66M
RSKD icon
116
Riskified
RSKD
$712M
$4.17M 0.2%
880,786
+108,266
+14% +$502K
TFX icon
117
Teleflex
TFX
$5.89B
$4.09M 0.19%
+22,981
New +$4.72M
SIRI icon
118
SiriusXM
SIRI
$9.7B
$4.08M 0.19%
+178,908
New +$4.56M
WRBY icon
119
Warby Parker
WRBY
$3.26B
$3.99M 0.19%
164,946
-218,931
-57% -$4.47M
HXL icon
120
Hexcel
HXL
$7.63B
$3.91M 0.19%
+62,376
New +$3.85M
SNV
121
PUT
DELISTED
Synovus
SNV
$3.84M 0.18%
+75,000
New +$3.89M
LEA icon
122
Lear
LEA
$8.05B
$3.83M 0.18%
+40,400
New +$4.02M
LKQ icon
123
LKQ Corp
LKQ
$6.22B
$3.76M 0.18%
102,440
-76,612
-43% -$2.93M
ATNI icon
124
ATN International
ATNI
$494M
$3.66M 0.17%
+217,557
New +$5.09M
GNTX icon
125
Gentex
GNTX
$5.02B
$3.64M 0.17%
126,842
-19,932
-14% -$596K
3 4
5
6 7

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Invenomic Capital Management held 185 positions worth $2.1B, up 15% from $1.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Invenomic Capital Management deployed $321M of net new capital in Q4 2024, opening 43 new positions and adding to 48 existing holdings. Its largest new stake was Prologis: 207,979 shares worth $22M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was M&T Bank, an estimated $36.8M trimmed.

  • Invenomic Capital Management's largest Q4 2024 buy was Prologis: 207,979 shares worth $22M.
  • Invenomic Capital Management added most to Dentsply Sirona in Q4 2024, an estimated $37.3M increase.
  • Invenomic Capital Management's biggest Q4 2024 reduction was M&T Bank, cutting an estimated $36.8M.
  • Invenomic Capital Management fully exited Warner Bros in Q4 2024, selling an estimated $23.6M.
  • Invenomic Capital Management's ten largest holdings make up 31% of its $2.1B portfolio in Q4 2024.
  • Invenomic Capital Management opened 43 new positions and closed 26 in Q4 2024.
  • Invenomic Capital Management's portfolio value rose 15% quarter-over-quarter to $2.1B.

Based on Invenomic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.